Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

about

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

Item

http://www.wikidata.org/entity/Q44955127

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

@en

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

@nl

type

Item

label

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

@en

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

@nl

prefLabel

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

@en

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

@nl

P1476

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors

@en

P2093

Luis Usán

http://www.w3.org/2001/XMLSchema#string

Sonsoles Sánchez-Palomino

http://www.w3.org/2001/XMLSchema#string

P2860

The challenge of viral reservoirs in HIV-1 infection

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

Latency in human immunodeficiency virus type 1 infection: no easy answers.

A review of low-dose ritonavir in protease inhibitor combination therapy.

P304

502-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.20118

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

José Alcamí

Mercedes Bermejo

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15221892

http://www.w3.org/2001/XMLSchema#string